The global interventional oncology market is expected to experience significant growth by 2030 due to the increasing number of cancer cases globally. Regionally, the North America region is projected to have expansive growth opportunities by 2030.
NEW YORK, May 27, 2022 /PRNewswire/ — Research Dive has added a new report to its offering titled, “Interventional Oncology Market by Product Type (Embolization Devices, Ablation Devices, and Support Devices), Caner Type (Liver Cancer, Lung Cancer, Bone Metastasis, Kidney Cancer, Breast Cancer, Prostate Cancer, and Other Cancers), End-user (Hospitals, Ambulatory Surgery Centers) , and Research & Academic Institutes), and Regional Analysis (North America, Europe, Asia-Pacificand LAMEA): Global Opportunity Analysis and Industry Forecast, 2022-2030.”
According to the report, the global interventional oncology market is anticipated to generate a revenue of $3,791.50 million and grow at a CAGR of 6.5% over the analysis timeframe from 2022 to 2030.
Dynamics of the Interventional Oncology Market
With the growing incidences of deaths caused due to cancer all across the globe, the interventional oncology market is expected to observe prominent growth during the estimated period. Besides, the inaccessible treatment options and late-stage diagnoses are the main factors expected to fortify the growth of the market over the forecast period. Moreover, the significant expansion of hospitals and healthcare equipment is expected to amplify the growth of the interventional oncology market during the analysis timeframe. However, the lower product penetration in the low-income regions may restrict the growth of the market throughout the forecast period.
Covid-19 Impact on the Interventional Oncology Market
The rise of the Covid-19 pandemic has badly affected the growth of the interventional oncology market. This is mainly because in many nations the clinic centers and hospitals have turned their operating centers into ICUs and the oncologist have been allocated to treating patients infected with the deadly virus. However, the implementation of advanced robotic-assisted technology by some leading players have helped oncologist to perform tumor ablation. This has uplifted the growth of the …